by European Public Health Alliance | Apr 12, 2017 | Statements
DOWNLOAD LETTER DOWNLOAD REFERENCES Brussels, 10 April 2017 Dear members of the Committee on Culture and Education, On 25 May 2016, the European Commission adopted a proposal to revise the Audiovisual Media Services Directive (AVMSD), which includes provisions...
by EPHA | Mar 27, 2017 | News Release, Statements
Brussels, 27 March 2017 The European Public Health Alliance (EPHA) is among 30 civil society organisations from 17 European countries filing coordinated patent oppositions on Hepatitis C medicine Sofosbuvir with the European Patent Office (EPO). The development of...
by EPHA | Mar 23, 2017 | Reports, Statements
British and European patients are likely to pay a high price for Brexit, concluded Brexit, Trade and Health, an event organised by the European Public Health Alliance (EPHA) in partnership with the University of Manchester and the Economic and Social Research Council...
by EPHA | Mar 22, 2017 | Reports, Statements
The challenge of Hepatitis C in Central and South Eastern Europe was at the heart of an event hosted by the MEP Friends of the Liver Interest Group co-chairs Dr Cristian Busoi, MEP, Dr Biljana Borzan, MEP and Dr Andrey Kovatchev, MEP and co-organised by the European...
by EPHA | Mar 6, 2017 | Opinion, Statements
Disclaimer: this briefing is based on a public hearing of the European Parliament Internal Market and Consumer Protection (IMCO) Committee held on 28th February 2017 on ‘The consequences of Brexit” On 17th January 2017 the Prime Minister of the United Kingdom (UK) set...
by European Public Health Alliance | Mar 2, 2017 | News Release, Statements
Brussels, 2 March 2017. The European Public Health Alliance welcomes the report on access to medicines adopted by the European Parliament Plenary this morning. The Parliament’s own initiative report addresses the challenge posed to national healthcare budgets by high...
